Immunoregulatory Effect of Short-Chain Fatty Acids from Gut Microbiota on Obstructive Sleep Apnea-Associated Hypertension
Li Zhang,Chih-Yuan Ko,Yi-Ming Zeng
DOI: https://doi.org/10.2147/NSS.S354742
2022-03-10
Nature and Science of Sleep
Abstract:Li Zhang, 1, 2, &ast Chih-Yuan Ko, 1– 4, &ast Yi-Ming Zeng 1, 2 1 Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, People's Republic of China; 2 Respiratory Medicine Center of Fujian Province, Quanzhou, 362000, People's Republic of China; 3 Department of Clinical Nutrition, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, People's Republic of China; 4 School of Public Health, Fujian Medical University, Fuzhou, Fujian, 350122, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yi-Ming Zeng; Chih-Yuan Ko, The Second Affiliated Hospital of Fujian Medical University, No. 34, Zhongshanbei Road, Licheng District, Quanzhou, 362000, Fujian Province, People's Republic of China, Tel +86 595-68196777, Email ; The intestine is the largest bacterial ecosystem and immune response organ of the human body. The microbiota regulates the metabolic and immune functions of the host through their metabolites. Short-chain fatty acids (SCFAs) are part of the metabolites of the gut microbiota (GM), providing energy to intestinal epithelial cells and regulating the immune system. A decrease in SCFA-producing bacteria, imbalanced effector T-helper cells (Th cells), and increasing corresponding inflammatory cytokine were found in both animal models and clinical patients with obstructive sleep apnea (OSA) and hypertension (HTN). Intervention with probiotics, prebiotics, or postbiotics in animal models simulating OSA-associated HTN restored blood pressure to normal, which allows the hypothesis that GM are involved in the pathophysiology of OSA-induced HTN patients through their metabolites' SCFAs; however, the exact regulatory mechanism is not completely clear. This review describes the potential mechanisms of SCFAs, a major metabolite of the GM, in the pathology of OSA-induced HTN, from the perspective of immune system regulation in the available studies. Keywords: obstructive sleep apnea, hypertension, gut microbiota dysbiosis, short-chain fatty acids, T cells Gut microbiota (GM) dysbiosis caused by obstructive sleep apnea (OSA) and hypertension (HTN) has received increasing attention. OSA and HTN are both common chronic diseases in middle-aged and elderly people; they share many common pathogenic factors, including age, gender, race, obesity, etc., so, they often coexist. 1 It is worth mentioning that obesity is the main risk factor for OSA. Morbid obesity is common in OSA patients, 2 and is also an important factor leading to HTN and HTN-related target organ damage. 3 However, excluding the common pathogenic factors still showed that OSA is an independent risk factor for HTN; about 35% of general OSA patients have primary HTN, 4 and the severity of HTN is positively correlated with the apnea-hypopnea index (AHI). 5,6 Additionally, OSA-related comorbidities mediate intermittent hypoxia or chronic inflammation depending on the severity of OSA such as cardiovascular events, ora-nasal disorders, or neurocognition. 7–9 In an animal model of chronic intermittent hypoxia (CIH)-induced OSA, a gavaged with cecal contents from OSA-induced HTN rats into normotensive OSA rats resulted in a significant increase in blood pressure after 7–14 days, suggesting a causal relationship between GM dysbiosis and HTN. 10 Gut commensal bacteria, through their metabolites such as short-chain fatty acids (SCFAs), trimethylamine-N-oxide (TMAO), and primary or secondary bile acids, communicated with the host through metabolism and immune host homeostasis. 11–13 Among these, SCFAs are the main metabolite produced by the fermentation of indigestible dietary fibre in the colon by numerous bacteria. Acetate, propionate, and butyrate account for more than 95% of SCFAs (the proportion structure in the intestine is 3:1:1). 13 Butyrate, a nutrient in the colon epithelium, is mainly absorbed in the colon epithelium and promotes the close connection between the intestinal epithelium. Propionate and butyrate are mainly metabolized by liver cells after passing through the portal vein, and only a small amount of SCFAs enters the systemic circulation. 14 SCFA-producing bacteria mainly include Anaerobic bacteria, Bifidobacterium, Lactobacillus, Streptococcus , and fungi. 15 SCFAs are involved in the host physiopathological processes through regulation of the immune system, 16 adipogenesis, 17 oxidative stress 18 and sensitivity to insulin, 19 and its receptors are widely present in the intestinal epithelium, adipose, pancreatic i -Abstract Truncated-
neurosciences,clinical neurology